Joosten, Johanna J. http://orcid.org/0000-0001-6381-8182
Longchamp, Grégoire
Khan, Mohammad F.
Lameris, Wytze
van Berge Henegouwen, Mark I.
Bemelman, Wilhelmus A.
Cahill, Ronan A.
Hompes, Roel
Ris, Frédéric
Article History
Received: 8 October 2021
Accepted: 13 February 2022
First Online: 23 February 2022
Declarations
:
: Prof. Dr. M. I. van Berge Henegouwen: unrestricted grants from Olympus and Stryker and consultancy for Johnson and Johnson Alesi, Surgical, Mylan, Braun, and Medtronic. All fees and grants paid to institution. Prof. Dr. W. A. Bemelman: speaker fees from Johnson & Johnson, Medtronic, Takeda, consulting fees from Takeda and Braun. Prof. Dr. R. Cahill; speaker fees from Stryker Corp, Olympus and Ethicon/J&J, research funding from Intuitive Corp and Medtronic and from the Irish Government (DTIF) in collaboration with IBM Research in Ireland and from EU Horizon 2020 in collaboration with Palliare. Dr. R. Hompes: unrestricted grant and materials Stryker European Operations B.V. Prof. Dr. F. Ris: Research grant from Quantgene and Johnson & Johnson, consulting for Arthrex, Distal Motion, Hollister, Freka, and Stryker. Dr. J. J. Joosten, Dr. W. Lameris, Dr. G. Longchamp, and Dr. M. F. Khan have no conflict or financial ties to disclose.